Both Semaglutide and Mounjaro represent innovative approaches to treating glucose control, and increasingly, weight management. It is a combined agonist that impacts two chemicals involved in glucose regulation: GLP-1 and a similar hormone. Mounjaro, often viewed as a product name for Tirzepatide